CARDIORENAL SYNDROME CRS Flashcards

(31 cards)

1
Q

What is the definition of Cardiorenal Syndrome (CRS)?

A

Overlap of heart and kidney dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the types of Cardiorenal Syndrome?

A
  • Type 1 (CRS-1)
  • Type 2 (CRS-2)
  • Type 3 (CRS-3)
  • Type 4 (CRS-4)
  • Type 5 (CRS-5)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What characterizes Type 1 Cardiorenal Syndrome (CRS-1)?

A

Acute heart failure leading to acute kidney injury (AKI).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the hemodynamic mechanisms in CRS-1?

A
  • Decreased kidney artery blood flow due to heart failure.
  • Cold Patients: Severe vasoconstriction, reduced effective circulating volume.
  • Warm Patients: Increased central venous pressure (CVP), pulmonary/systemic congestion.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the prevalence of CRS-1 in patients with acute decompensated heart failure?

A

25% of patients.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the biomarkers used for CRS-1?

A
  • Cystatin C
  • NGAL
  • Bioimpedance for fluid volume.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What diagnostic tools are used for CRS-1?

A
  • Echocardiography
  • Kidney Ultrasound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What treatments are typically used for CRS-1?

A
  • Diuretics
  • Beta-blockers
  • ACE inhibitors
  • ARBs
  • Inotropic support for cardiogenic shock.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What characterizes Type 2 Cardiorenal Syndrome (CRS-2)?

A

Chronic heart failure leading to chronic kidney disease (CKD).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the mechanisms involved in CRS-2?

A
  • Neurohormonal activation
  • Kidney hypoperfusion
  • Venous congestion
  • Inflammation
  • Oxidative stress.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What diagnostic tools are used for CRS-2?

A
  • Kidney Ultrasound
  • Echocardiography
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What management strategies are used for CRS-2?

A
  • Pharmacological: Diuretics, RAAS blockade, careful monitoring of kidney function.
  • Ultrafiltration for fluid overload when diuretics fail.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What characterizes Type 3 Cardiorenal Syndrome (CRS-3)?

A

Acute kidney injury leading to heart dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the mechanisms involved in CRS-3?

A
  • Immune modulation
  • RAAS activation
  • Sympathetic nervous system hyperactivity.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the epidemiology of CRS-3?

A

70% of ICU patients develop AKI, with high mortality rates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What diagnostic tools are used for CRS-3?

A
  • Kidney Ultrasound
  • Echocardiography
17
Q

What are the management stages in CRS-3?

A
  • Stage 1 (Risk): Avoid nephrotoxic drugs, monitor kidney function.
  • Stage 2 (Injury): Hemodynamic monitoring, electrolyte management.
  • Stage 3 (Failure): Renal replacement therapy (RRT) if needed.
18
Q

What characterizes Type 4 Cardiorenal Syndrome (CRS-4)?

A

Chronic kidney disease leading to cardiovascular disease.

19
Q

What are the mechanisms involved in CRS-4?

A
  • Hypertension
  • Volume overload
  • Hyperphosphatemia
  • Chronic inflammation.
20
Q

What is the epidemiology of CRS-4?

A

Increased cardiovascular risk with declining eGFR.

21
Q

What diagnostic tools are used for CRS-4?

A
  • Echocardiography
  • Kidney Ultrasound
22
Q

What management strategies are used for CRS-4?

A
  • Pharmacological: ACE inhibitors, ARBs, beta-blockers, phosphate binders.
  • Lifestyle: Control of hypertension, dyslipidemia, and volume overload.
23
Q

What characterizes Type 5 Cardiorenal Syndrome (CRS-5)?

A

Systemic disease leading to simultaneous heart and kidney dysfunction.

24
Q

What are the mechanisms involved in CRS-5?

A
  • Inflammation
  • Immune dysregulation
  • Autonomic dysfunction.
25
What biomarkers are associated with CRS-5?
* Lipopolysaccharide binding protein * Procalcitonin * CRP * IL-6.
26
What management strategies are used for CRS-5?
* Hemodynamic Stability: Fluid therapy, vasopressors, inotropes. * Renal Support: Avoid nephrotoxins, early RRT if indicated.
27
True or False: Cystatin C is a better predictor of long-term outcomes in ADHF than serum creatinine.
True.
28
What is a common issue in CRS-2 that may require alternative strategies?
Diuretic resistance.
29
What is the high mortality rate associated with CRS-3 primarily due to?
AKI leading to acute heart dysfunction.
30
What cardiovascular risk increases with declining eGFR in CRS-4?
Increased cardiovascular risk.
31
Fill in the blank: CRS-5 involves simultaneous heart and kidney dysfunction due to _______.
[systemic diseases like sepsis].